Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study

BACKGROUND: Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing is needed to improve their engagement in the HCV care ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Ilhame, Donadille, Cécile, Protopopescu, Camelia, Michels, David, Herin, Joris, Pladys, Adélaïde, Bader, Danièle, Carrieri, Patrizia, Roux, Perrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387207/
https://www.ncbi.nlm.nih.gov/pubmed/37516889
http://dx.doi.org/10.1186/s12954-023-00841-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387207/
https://www.ncbi.nlm.nih.gov/pubmed/37516889
http://dx.doi.org/10.1186/s12954-023-00841-7

Ejemplares similares